Company Filing History:
5 out of 336 
2 out of 832,843 Years Active: 2014-2024
Title: Xuhui Lai: Innovator in High Fidelity Restriction Endonucleases
Introduction
Xuhui Lai is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the development of high fidelity restriction endonucleases. With a total of 7 patents to his name, Lai's work has had a substantial impact on genetic engineering and molecular biology.
Latest Patents
Lai's latest patents focus on methods and compositions for engineering mutant enzymes with reduced star activity. These mutant enzymes exhibit a fidelity index (FI) in a specified buffer that is greater than that of the non-mutated enzyme in the same buffer. This innovation enhances the precision of genetic modifications, making it a valuable tool for researchers in the field.
Career Highlights
Throughout his career, Xuhui Lai has worked with notable companies, including New England Biolabs, Inc. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking advancements in enzyme technology.
Collaborations
Lai has collaborated with esteemed colleagues such as Zhenyu Zhu and Aine Quimby. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Xuhui Lai's contributions to the field of biotechnology, particularly through his patents on high fidelity restriction endonucleases, highlight his role as a leading inventor. His work continues to influence the landscape of genetic engineering and molecular biology.